Vaxart (VXRT) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Vaxart Revenue Highlights

Latest Revenue (Y)

$28.70M

Latest Revenue (Q)

$4.93M

Main Segment (Y)

Government Contract

Vaxart Revenue by Period

Vaxart Revenue by Year

Date	Revenue	Change
2024-12-31	$28.70M	288.94%
2023-12-31	$7.38M	6796.26%
2022-12-31	$107.00K	-88.00%
2021-12-31	$892.00K	-77.95%
2020-12-31	$4.05M	-58.97%
2019-12-31	$9.86M	137.12%
2018-12-31	$4.16M	-28.77%
2017-12-31	$5.84M	-34.39%
2017-06-30	$8.90M	-4.30%
2016-06-30	$9.30M	-62.20%
2015-06-30	$24.60M	-64.19%
2014-06-30	$68.70M	104.46%
2013-06-30	$33.60M	126.45%
2011-12-31	$14.84M	-57.61%
2010-12-25	$35.01M	233.73%
2009-12-26	$10.49M	100.00%
2008-12-27	-	100.00%
2007-12-29	-	-100.00%
2006-12-30	$89.87M	-16.83%
2005-12-31	$108.06M	-24.00%
2004-12-25	$142.18M	-19.47%
2003-12-27	$176.57M	-9.90%
2002-12-28	$195.97M	-16.55%
2001-12-29	$234.83M	2.64%
2000-12-30	$228.78M	-2.06%
1999-12-31	$233.60M	-3.91%
1998-12-31	$243.10M	6.30%
1997-12-31	$228.70M	-4.67%
1996-12-31	$239.90M	18.76%
1995-12-31	$202.00M	22.65%
1994-12-31	$164.70M	62.11%
1993-12-31	$101.60M	23.30%
1992-12-31	$82.40M	-

Vaxart generated $28.70M in revenue during NA 2024, up 288.94% compared to the previous quarter, and up 291.02% compared to the same period a year ago.

Vaxart Revenue by Quarter

Date	Revenue	Change
2024-09-30	$4.93M	-22.93%
2024-06-30	$6.40M	193.49%
2024-03-31	$2.18M	-32.79%
2023-12-31	$3.25M	627.58%
2023-09-30	$446.00K	-67.16%
2023-06-30	$1.36M	101.19%
2023-03-31	$675.00K	2968.18%
2022-12-31	$22.00K	100.00%
2022-09-30	-	100.00%
2022-06-30	-	-100.00%
2022-03-31	$85.00K	14.86%
2021-12-31	$74.00K	-63.00%
2021-09-30	$200.00K	78.57%
2021-06-30	$112.00K	-77.87%
2021-03-31	$506.00K	42.13%
2020-12-31	$356.00K	34.34%
2020-09-30	$265.00K	-49.33%
2020-06-30	$523.00K	-81.98%
2020-03-31	$2.90M	-25.89%
2019-12-31	$3.92M	762.56%
2019-09-30	$454.00K	434.12%
2019-06-30	$85.00K	-98.43%
2019-03-31	$5.41M	206.00%
2018-12-31	$1.77M	528.83%
2018-09-30	$281.00K	-53.78%
2018-06-30	$608.00K	-59.55%
2018-03-31	$1.50M	-44.33%
2017-12-31	$2.70M	2600.00%
2017-09-30	$100.00K	-
2017-06-30	$100.00K	-97.96%
2017-05-02	$4.90M	28.95%
2016-12-31	$3.80M	3700.00%
2016-09-30	$100.00K	-80.00%
2016-06-30	$500.00K	-90.57%
2016-03-31	$5.30M	211.76%
2015-12-31	$1.70M	-
2015-09-30	$1.70M	-58.54%
2015-06-30	$4.10M	-30.51%
2015-03-31	$5.90M	-57.55%
2014-12-31	$13.90M	1885.71%
2014-09-30	$700.00K	-91.67%
2014-06-30	$8.40M	-71.53%
2014-03-31	$29.50M	59.46%
2013-12-31	$18.50M	50.41%
2013-09-30	$12.30M	32.92%
2013-06-30	$9.25M	-25.94%
2013-03-31	$12.50M	20.32%
2012-12-31	$10.39M	1543.35%
2012-09-30	$632.00K	0.16%
2012-06-30	$631.00K	-0.16%
2012-03-31	$632.00K	-24.31%
2011-12-31	$835.00K	-23.11%
2011-09-24	$1.09M	-70.99%
2011-06-25	$3.74M	-59.18%
2011-03-26	$9.17M	124.83%
2010-12-25	$4.08M	-66.92%
2010-09-25	$12.34M	154.38%
2010-06-26	$4.85M	-64.71%
2010-03-27	$13.74M	31.00%
2009-12-26	$10.49M	100.00%
2009-09-26	-	100.00%
2009-06-27	-	100.00%
2009-03-28	-	100.00%
2008-12-27	-	100.00%
2008-09-27	-	100.00%
2008-06-28	-	100.00%
2008-03-29	-	100.00%
2007-12-29	-	-

Vaxart generated $4.93M in revenue during Q3 2024, up -22.93% compared to the previous quarter, and up 363.25% compared to the same period a year ago.

Vaxart Revenue Breakdown

Vaxart Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Government Contract	$65.40M	-	-	-	-
Non Cash Royalty Revenue	$3.84M	$3.92M	$107.00K	-	-
Grant	-	$3.46M	-	-	-
Customer Service Contracts	-	-	-	$198.00K	-

Vaxart's latest annual revenue breakdown by segment (product or service), as of Dec 24: Government Contract (94.45%), and Non Cash Royalty Revenue (5.55%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18
Non Cash Royalty Revenue	$3.22M	$40.00K	$585.00K	$3.47M	$446.00K	$74.00K	$200.00K	$112.00K	$493.00K	$351.00K	$263.00K	$238.00K	$34.00K	$2.91M	$16.00K	$1.75M	$1.46M	-	-	-
Government Contract	-	$65.45M	$1.60M	$20.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grant	-	-	-	$79.00K	$1.66M	$1.33M	$397.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer Service Contracts	-	-	-	-	-	-	-	-	-	-	-	-	$2.00K	$92.00K	$99.00K	$312.00K	$94.00K	-	-	-

Vaxart's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Non Cash Royalty Revenue (100.00%).

Vaxart Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 21	Dec 20	Dec 19	Dec 18
Government Contract	-	$-20.00K	$1.34M	-
Customer Service Contracts	-	$198.00K	-	-
Non Cash Royalty Revenue	-	-	-	$1.48M

Quarterly Revenue by Country

Country	Jun 18	Mar 18
JAPAN	$1.00K	$28.00K

Vaxart's latest quarterly revenue breakdown by geography, as of Jun 18: JAPAN (100.00%).

Vaxart Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
NVAX	Novavax	$682.16M	$415.48M
VXRT	Vaxart	$28.70M	$4.93M
OCGN	Ocugen	$4.05M	$1.14M
CODX	Co-Diagnostics	$3.92M	$641.14K
INO	Inovio Pharmaceuticals	-	-

VXRT Revenue FAQ

What is Vaxart’s yearly revenue?

Vaxart's yearly revenue for 2024 was $28.7M, representing an increase of 288.94% compared to 2023. The company's yearly revenue for 2023 was $7.38M, representing an increase of 6796.26% compared to 2022. VXRT's yearly revenue for 2022 was $107K, representing a decrease of -88.00% compared to 2021.

What is Vaxart’s quarterly revenue?

Vaxart's quarterly revenue for Q3 2024 was $4.93M, a -22.93% decrease from the previous quarter (Q2 2024), and a 1006.05% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $6.4M, a 193.49% increase from the previous quarter (Q1 2024), and a 371.35% increase year-over-year (Q2 2023). VXRT's quarterly revenue for Q1 2024 was $2.18M, a -32.79% decrease from the previous quarter (Q4 2023), and a 223.11% increase year-over-year (Q1 2023).

What is Vaxart’s revenue growth rate?

Vaxart's revenue growth rate for the last 3 years (2022-2024) was 26722.43%, and for the last 5 years (2020-2024) was 609.34%.

What are Vaxart’s revenue streams?

Vaxart's revenue streams in c 24 are Government Contract, and Non Cash Royalty Revenue. Government Contract generated $65.4M in revenue, accounting 94.45% of the company's total revenue Non Cash Royalty Revenue generated $3.84M in revenue, accounting 5.55% of the company's total revenue, down -1.99% year-over-year.

What is Vaxart’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Vaxart was Government Contract. This segment made a revenue of $65.4M, representing 94.45% of the company's total revenue.